dc.contributor.author | Mahroum, Naim | |
dc.contributor.author | Shoenfeld, Yehuda | |
dc.date.accessioned | 2022-01-10T08:22:23Z | |
dc.date.available | 2022-01-10T08:22:23Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.citation | Mahroum, N. ve Shoenfeld, Y. (2022). COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells. International Journal of Rheumatic Diseases, 25(1), 5-6. https://doi.org/10.1111/1756-185X.14259 | en_US |
dc.identifier.issn | 1756-1841 | |
dc.identifier.issn | 1756-185X | |
dc.identifier.uri | https://doi.org/10.1111/1756-185X.14259 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/8791 | |
dc.description.abstract | The increasing numbers of vaccinated people against COVID-19 worldwide has permitted better visualization and understanding of possible adverse effects, particularly those related to autoimmune phenomena. In this regard, Sachinidis and Garyfallos have lately ad-dressed a possible explanation for these phenomena emphasizing the role of age-associated B cells. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Autoimmunity | en_US |
dc.subject | COVID-19 Vaccine | en_US |
dc.subject | mRNA Vaccine | en_US |
dc.subject | SARS-CoV-2 Vaccine | en_US |
dc.title | COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells | en_US |
dc.type | editorial | en_US |
dc.relation.ispartof | International Journal of Rheumatic Diseases | en_US |
dc.department | İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi | en_US |
dc.authorid | 0000-0002-7919-1326 | en_US |
dc.identifier.volume | 25 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 5 | en_US |
dc.identifier.endpage | 6 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.doi | 10.1111/1756-185X.14259 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.identifier.scopusquality | Q3 | en_US |